- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02215278
A Multiple Meal Stable Iron Isotope Study in Iron Deficient Rwandese Women to Investigate the Performance of Low Phytic Acid Bean Seeds
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Huye
-
Butare, Huye, Rwanda
- University of Rwanda
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- non pregnant women, non lactating women
- 18-30 years
- <65 kg
Exclusion Criteria:
- metabolic, chronic or gastrointestinal disease
- long term medication
- blood donation within the last 6 month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: low phytic acid bean (lpa variety)
|
|
|
EXPERIMENTAL: high iron biofortified bean variety
|
|
|
EXPERIMENTAL: normal iron, normal phytic acid bean
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Iron bioavailability from lpa bean variety compared to an iron biofortified variety
Time Frame: 2 month
|
Iron bioavailability is determined by measuring the amounts of isotopic labels in blood 14 d after administration of the test meals. It is calculated on the basis of the shift in iron isotope ratios and on the estimated amount of iron circulating in the body. Circulating iron is calculated based on the blood volume estimated from height and weight and measured Hb concentration. The calculations are based on the principles of isotope dilution. For calculation of fractional absorption, 80% incorporation of the absorbed Fe into red blood cells is assumed. Isotopic analysis are performed by negative thermal ionization mass spectrometry using a magnetic sector field mass spectrometer equipped with a multi-collector system for simultaneous ion beam detection |
2 month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nicolai Petry, PhD, GroundWork
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- lpa_002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enrichment of Blood With Stable Iron Isotopes
-
Swiss Federal Institute of TechnologyJomo Kenyatta University of Agriculture and TechnologyCompletedIron-deficiency | Iron Absorption | Ferritin Threshold | Stable Iron IsotopesKenya
-
Swiss Federal Institute of TechnologyCompletedBlood Iron Isotope EnrichmentSwitzerland
-
Swiss Federal Institute of TechnologyCompletedEnrichment of BloodRwanda
-
Ain Shams UniversityCompletedLactoferrin With Ferrous Gluconate More Superior Than Ferrous Gluconate Alone in Treatment of Iron Deficiency AnemiaEgypt
-
China-Japan Friendship HospitalRecruitingHeart Failure With Preserved Ejection Fraction | Acute Heart Failure | Iron DeficienciesChina
-
China-Japan Friendship HospitalRecruitingIron Deficiency | Heart Failure With Reduced Ejection Fraction | Acute Heart FailureChina
-
Syed Hamza MufarrihAmerican Regent, Inc.RecruitingHeart Failure | Iron Deficiency | Heart Failure With Reduced Ejection Fraction (HFrEF) | Heart Failure With Preserved Ejection Fraction (HFPEF) | Iron-deficiency Anemia (IDA)United States
-
Jordan Collaborating Cardiology GroupCompletedIron Deficiency | Heart Failure With Reduced Ejection Fraction | Heart Failure With Mildly Reduced Ejection FractionJordan
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsRecruitingIron-deficiency | Heart Failure With Preserved Ejection FractionUnited States
-
Swiss Federal Institute of TechnologyCheikh Anta Diop University, SenegalCompletedAnemia; Deficiency, Nutritional, With Poor Iron AbsorptionSenegal
Clinical Trials on 10 x 55 g/ bean per arm
-
University Hospital, GrenobleCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche...Completed
-
Medical College of WisconsinNot yet recruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Jonsson Comprehensive Cancer CenterTerminatedResectable Pancreatic CarcinomaUnited States
-
University of HohenheimLactopia GmbH, An der Römerbrücke 16, 66121 Saarbrücken, GermanyCompleted
-
VLP TherapeuticsStanford UniversityRecruitingHead and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Solid Tumors | Head and Neck Squamous Cell Cancer | Head Neck Cancer | Oral Cavity Carcinoma | HNSCC | Oral Cavity | Squamous Cell Carcinoma, Head And Neck | Head and Neck Cancers- Squamous Cell | Squamous Cell Head and Neck Carcinoma | SCCHN and other conditionsUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Merck Sharp & Dohme LLCWithdrawnCardiovascular Diseases | Hyperlipidemia
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
St. Jude Children's Research HospitalTerminated
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico